ScholarLens Back to search
2012•Hainan yixueRequires access

Clinical observation on the effect of galantamine in the treatment of mild cognitive impairment

Wei Ya

Open publisher page 1 citations

Abstract

Objective To observe the efficacy and safety of galantamine in the treatment of mild cognitive impairment(MCI).Methods Eighty patients with diagnosed MCI were divided into two groups by their number of visiting time:the control group(patients with odd numbers,treated by regular therapy) and the study group(patients with even numbers,treated by galantamine),each with 40 cases.Treatment course is 3 months.The clinical efficacy was evaluated before treatment,as well as 1 month and 3 months after treatment through mini mental status examination(MMSE).Results Three months after treatment,MMSE scores were significantly increased both in the study group and the control group,compared with that before treatment.And the change in the study group is particularly obvious.Conclusion Galantamine can significantly improve the cognitive function in patients with mild cognitive impairment,which is also safe and reliable.

About this research paper

What this paper is about

Objective To observe the efficacy and safety of galantamine in the treatment of mild cognitive impairment(MCI).Methods Eighty patients with diagnosed MCI were divided into two groups by their number of visiting time:the control group(patients with odd numbers,treated by regular therapy) and the study group(patients with even numbers,treated by galantamine),each with 40 cases.Treatment course is 3 months.The clinical efficacy was evaluated before treatment,as well as 1 month and 3 months after treatment through mini mental status examination(MMSE).Results Three months after treatment,MMSE scores were significantly increased both in the study group and the control group,compared with that before treatment.And the change in the study group is particularly obvious.Conclusion Galantamine can significantly improve the cognitive function in patients with mild cognitive impairment,which is also safe and reliable.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the efficacy and safety of galantamine in the treatment of mild cognitive impairment(MCI).Methods Eighty patients with diagnosed MCI were divided into two groups by their number of visiting time:the control group(patients with odd numbers,treated by regular therapy) and the study group(patients with even numbers,treated by galantamine),each with 40 cases.Treatment course is 3 months.The clinical efficacy was evaluated before treatment,as well as 1 month and 3 months after treatment through mini mental status examination(MMSE).Results Three months after treatment,MMSE scores were significantly increased both in the study group and the control group,compared with that before treatment.And the change in the study group is particularly obvious.Conclusion Galantamine can significantly improve the cognitive function in patients with mild cognitive impairment,which is also safe and reliable.

Key concepts: Galantamine, Medicine, Cognitive impairment, Cognition, Treatment and control groups, Clinical efficacy, Internal medicine, Psychiatry

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical observation on the effect of galantamine in the treatment of mild cognitive impairment — Research Paper | ScholarLens